ALLERCOAT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ALLERCOAT Trademark

Serial Number: 79218575 • Registration: 5510488

ALLERCOAT is a trademark filed by EUROIMMUN Medizinische Labordiagnostika AG on June 23, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

EUROIMMUN Medizinische Labordiagnostika AG

Seekamp 31
Lübeck 23560 , DE

Entity Type: 25

Trademark Details

Filing Date

June 23, 2017

Registration Date

July 10, 2018

Published for Opposition

April 24, 2018

Cancellation Date

January 24, 2025

Goods & Services

Measuring, detecting and monitoring instruments, devices and regulators, all the foregoing being medical laboratory research apparatus for use in preparing, processing and evaluating diagnostic samples, for detecting allergies; Sensors for sensing antibodies, antigens, allergens, tissue, proteins, nucleotides and pathogens and detectors for detecting antibodies, antigens, allergens, tissue, proteins, nucleotides and pathogens, in particular UV, fluorescence and chemiluminescence detectors, all for preparing, processing and evaluating diagnostic samples for detecting neurological diseases, infectious diseases, autoimmune diseases, cancer and allergies; Apparatus for recording, transmission or reproduction of diagnostic data, sound or images, in particular cameras, microscopes, photometers, microplate photometers, ELISA (enzyme-linked immunosorbent assay) microplate readers

Diagnostic agents, in particular diagnostic agents for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, diagnostic agents for medical and veterinary purposes, in particular immobilised proteins on a support or a support material, in particular on a biochip, microsphere, test strip, blot, microplate or membrane; reagents for medical and veterinary diagnostic purposes; reagents for medical and veterinary diagnostic purposes, in particular immobilised proteins on a support or a support material, in particular on a paper ring, biochip, microsphere, test strip, blot, microplate or membrane

Diagnostic preparations, diagnostic agents and diagnostic substances for scientific purposes, in particular tissue sections and immobilised proteins on a carrier or a carrier material, in particular on a biochip, microsphere, test strip, blot, microplate or membrane

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
May 7, 2026 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Mar 11, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 11, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 24, 2025 INTR
CANCELLED SECTION 71
Jan 24, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 10, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2018 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Oct 18, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Oct 18, 2018 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 10, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 10, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 24, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 4, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 27, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2018 REAP
REFUSAL PROCESSED BY IB
Nov 17, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 1, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 1, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 26, 2017 RFCR
NON-FINAL ACTION WRITTEN
Oct 25, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 24, 2017 MAFR
ASSIGNED TO EXAMINER
Oct 20, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 19, 2017 REPR